Related Experiment Video
Updated: Jul 12, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Mdm2 plays a positive role as an effector of p53-dependent responses
Luciana E Giono1, James J Manfredi
1Department of Oncological Sciences, Mount Sinai School of Medicine, New York, New York, USA.
Abstract:
The p53 tumor suppressor is negatively regulated in cells by the Mdm2 protein. Mdm2 has therefore been the focus of intensive research aiming at using it as a target for cancer therapy with the ultimate goal of restoring p53 activity. Several studies have attempted to ablate Mdm2 expression or disrupt its interaction with p53 in cancer cells. While the p53-Mdm2 duo has concentrated a lot of attention, multiple new and diverse functions and targets of Mdm2 have been uncovered. Downregulation of Mdm2 using an siRNA approach has recently provided evidence for a new role of Mdm2 in the p53 response, by modulating the inhibition of the cyclin-dependent kinase 2 (cdk2) by p21. Here, this and other recent findings are discussed that support a new role for Mdm2 in the regulation of p53 response.
Insights
The Mdm2 protein regulates the p53 tumor suppressor. New research reveals Mdm2
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- The Mdm2 protein negatively regulates the p53 tumor suppressor.
- Mdm2 is a key target for cancer therapy aimed at restoring p53 activity.
- Previous research focused on ablating Mdm2 or disrupting its interaction with p53.
Purpose of the Study:
- To discuss new findings on Mdm2's diverse functions.
- To highlight Mdm2's emerging role in regulating the p53 response.
- To explore Mdm2's modulation of cyclin-dependent kinase 2 (cdk2) inhibition by p21.
Main Methods:
- RNA interference (siRNA) for Mdm2 downregulation.
- Analysis of Mdm2's impact on the p53 pathway.
- Investigation of Mdm2's interaction with p21 and cdk2.
Main Results:
- Mdm2 downregulation via siRNA revealed a novel function in the p53 response.
- Mdm2 modulates the inhibition of cyclin-dependent kinase 2 (cdk2) by p21.
- Evidence supports a new regulatory role for Mdm2 in the p53 pathway.
Conclusions:
- Mdm2 plays a more complex role in the p53 response than previously understood.
- Mdm2's functions extend beyond its interaction with p53.
- Further research into Mdm2's novel roles could offer new therapeutic strategies in cancer.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

